Organon layoffs, on the record
Every job cut, severance charge and restructuring Organon reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 10,000 to over 10,000.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 10,000 | As of December 31, 2023 |
| 10-K for 2024 | over 10,000 | As of December 31, 2024 |
| 10-K for 2025 | over 10,000 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryIn 2022, Organon began restructuring to optimize internal operations by reducing headcount in selected markets and functions, restructuring about 130 positions.
Word for word“In 2022, Organon initiated restructuring activities to optimize its internal operations by reducing headcount through selected markets and functions.” 10-K for 2023
Our summaryIn the fourth quarter of 2023, Organon implemented additional restructuring by reducing headcount in certain markets and functions, expected to cut headcount about 3% over twelve months.
Word for word“As a result of these activities, the Company's headcount will be reduced by approximately 3 % over the next twelve months.” 10-K for 2023
Our summaryOrganon recorded headcount-related restructuring expense for 2023, of which most relates to fourth-quarter activities tied to optimizing internal operations.
Word for word“For the year ended December 31, 2023, we incurred $62 million of headcount-related restructuring expense, of which $58 million is due to activities initiated in the fourth quarter related to the ongoing optimization of our internal operations.” 10-K for 2023
Our summaryOrganon reported severance liability activity for restructuring and expects remaining severance payments to be made by the end of 2024.
Word for word“Organon expects the remaining severance payments associated with the restructuring activities to be paid by the end of 2024.” 10-K for 2023
Our summaryOrganon implemented additional restructuring activities in the first quarter of 2024 by reducing headcount, primarily in research and development, as part of ongoing optimization of internal operations.
Word for word“For the year ended December 31, 2024, we incurred $31 million of headcount-related restructuring expense related to the ongoing optimization of our internal operations, primarily the research and development function.” 10-K for 2024
Our summaryOrganon began restructuring in the fourth quarter of 2023 by reducing headcount in certain markets and functions; combined with the first quarter 2024 actions, headcount was reduced by about 5% by the end of 2024.
Word for word“As a result of these combined activities, the Company's headcount was reduced by approximately 5 % by the end of 2024.” 10-K for 2024
Our summaryOrganon implemented additional restructuring initiatives in the first quarter of 2025 that will result in a further headcount reduction.
Word for word“During the first quarter of 2025, we implemented additional restructuring initiatives that will drive operational efficiencies in 2025, and will result in an approximate 5 % headcount reduction.” 10-K for 2024
Our summaryOrganon reported that severance liabilities related to restructuring fell from $61 million to $14 million during 2024, with remaining severance payments expected within the next twelve months.
Word for word“Organon expects the remaining severance payments associated with the restructuring activities to be within the next twelve months.” 10-K for 2024
Our summaryThe company said it carried out restructuring initiatives to drive operational efficiencies and cost savings and to reduce its long-term debt.
Word for word“Our efforts included implementing restructuring initiatives aimed at driving operational efficiencies and cost savings initiatives and reducing our outstanding long-term debt.” 10-K for 2025
| Fiscal year ended | Severance costs | Restructuring charges | Cash paid for restructuring |
|---|---|---|---|
| 2019-12-31 | $70 million | $78 million | — |
| 2020-12-31 | $30 million | $60 million | — |
| 2021-12-31 | — | $3 million | — |
| 2022-12-31 | $28 million | $28 million | $8 million |
| 2023-12-31 | $62 million | $62 million | $21 million |
| 2024-12-31 | $31 million | $31 million | $78 million |
| 2025-12-31 | $95 million | $95 million | $101 million |
Organon has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Organon’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.